# Intranasal Oxytocin for the Treatment of Alcohol Use Disorder

> **NCT03878316** · PHASE2 · COMPLETED · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 100 (actual)

## Conditions studied

- Alcohol Use Disorder
- Alcohol Misuse

## Interventions

- **DRUG:** Instranasal Oxytocin

## Key facts

- **NCT ID:** NCT03878316
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-29
- **Primary completion:** 2023-10-13
- **Final completion:** 2023-10-13
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03878316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03878316, "Intranasal Oxytocin for the Treatment of Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03878316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*